MoonLake Immunotherapeutics Stock (MLTX)

Track MoonLake Immunotherapeutics stock through TheStreet Pro's latest coverage, including articles, Daily Diary mentions, TheStreet Pro portfolio activity, contributor watchlist signals, and Pro price levels.

At close

$17.90

▼ -0.82 (-4.38%)

Jun 5, 4:00 PM ET

After-hours

$17.93

▲ +0.03 (+0.17%)

Jun 5, 7:04 PM ET

Market Cap

$1.34B

P/E Ratio

—

1Y Return

-63.33%

EPS (TTM)

-$3.87

Read the latest TheStreet Pro articles mentioning MoonLake Immunotherapeutics, including market roundups, portfolio updates, trade ideas, and investing analysis.

Articles

3 articles

trade-ideas I'm Over the Moon About This Promising Biotech
Bret JensenAug 17, 2025
MLTX MRK
trade-ideas Two Biotechs That Could Get an M&A Boost
Bret JensenJun 4, 2025
MLTX SNY MRK
trade-ideas I'm Eyeing 2 Promising Biotech Plays as Oversold Market Gets Under My Skin
Bret JensenOct 25, 2024
MLTX NTLA

Daily Diary Mentions

1 mention

Sep 30 · 6:30 PMConcentration Can Kill
* Another lesson learned... This is a story of a well-regarded multi-billion-dollar healthcare hedge fund, BVF (Biotechnology Value Fund), founded in 1993, which had a near 35% holding (19.7 million shares) in MoonLake I…
MLTX
Read in context ›